Entrada Therapeutics Inc (TRDA)

17.74 +0.14 (+0.82%) USD  |  NASDAQ  |  Nov 04, 16:00
17.76 +0.01 (+0.06%) After-Hours: 20:00
More

Entrada Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for TRDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Return on Net Operating Assets Data

View and export this data back to 2023. Upgrade now.
Date Value
June 30, 2024 --
March 31, 2024 --
Date Value
December 31, 2023 --

Return on Net Operating Assets Range, Past 5 Years

Upgrade
Minimum
Dec 2023
Upgrade
Maximum
Jun 2024
Upgrade
Average
Upgrade
Median
Mar 2024

Return on Net Operating Assets Benchmarks

Fulcrum Therapeutics Inc Upgrade
Sarepta Therapeutics Inc Upgrade
Catalyst Pharmaceuticals Inc Upgrade
Vertex Pharmaceuticals Inc Upgrade
Regenxbio Inc Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade